Deadline to Submit Expression of Interest: October 22, 2021
Deadline for Full Proposal: November 1, 2021
Study Start Date: November 2021
Study Deadline: May 23, 2022
Budget: up to £40,000 (~$67,000 CAD)
The ICBP is commissioning research that will develop an understanding how COVID-19 impacted cancer services and policies in ICBP jurisdictions. There is a particular interest in collating each jurisdictions’ mitigation strategies and understanding how this activity may have minimized the impact on cancer services and outcomes during and outwith the COVID-19 pandemic.
One of the jurisdictions of interest is Canada, and ICPB is specifically seeking applications from Canadian teams during this extended application phase.
The ICBP Programme Management Team are not prescribing a methodology to allow flexibility for researcher proposals. They expect the design and implementation of this work to take into consideration ongoing restrictions and limitations posed by the COVID-19 pandemic.
ICBP anticipates that the research methodology may include the following:
- Primary and secondary data collection including primarily qualitative methods (though assessment of quantitative data may be required)
- A literature review of key local and national policies and practices
- A stakeholder consultation
- Key informant interviews
The successful applicant will be responsible for the study, but ICBP does expect considerable collaboration with the PMT and regular updates, as described in the outputs. Applicants should have demonstrable expertise, previous experience, and a good understanding of health systems, health policy, and experience dealing with international comparisons.
The outputs are as follows:
a. Scoping paper including approach, methodology and timeline
b. A summary of the methodology, its strengths and weaknesses and and interview topic guide or other research instrument as needed
c. Draft Final Report and Final Report for external publication, presenting the full findings.
d. An executive summary of the key findings.
e. A full account of all research findings.
f. Up to 5 presentations of the report to relevant conferences and key stakeholders
This list is not exhaustive and additional outputs may be considered.